Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Vycor Medical (VYCO) Gross Margin (2016 - 2025)

Vycor Medical has reported Gross Margin over the past 16 years, most recently at 80.45% for Q4 2025.

  • Quarterly Gross Margin fell 685.0% to 80.45% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 83.78% through Dec 2025, down 573.0% year-over-year, with the annual reading at 83.78% for FY2025, 573.0% down from the prior year.
  • Gross Margin was 80.45% for Q4 2025 at Vycor Medical, down from 87.96% in the prior quarter.
  • Over five years, Gross Margin peaked at 92.0% in Q2 2021 and troughed at 80.45% in Q4 2025.
  • The 5-year median for Gross Margin is 89.19% (2022), against an average of 88.27%.
  • Year-over-year, Gross Margin surged 411bps in 2021 and then plummeted -768bps in 2025.
  • A 5-year view of Gross Margin shows it stood at 88.39% in 2021, then dropped by -2bps to 86.3% in 2022, then grew by 0bps to 86.37% in 2023, then rose by 1bps to 87.29% in 2024, then dropped by -8bps to 80.45% in 2025.
  • Per Business Quant, the three most recent readings for VYCO's Gross Margin are 80.45% (Q4 2025), 87.96% (Q3 2025), and 83.66% (Q2 2025).